Po-Yuam Lin

Title: Po-Yuam Lin: Innovator in Prostate Cancer Detection

Introduction

Po-Yuam Lin is a notable inventor based in Cleveland, OH (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of prostate cancer. His innovative work has led to the development of a unique detection system that can potentially improve early diagnosis and treatment outcomes for patients.

Latest Patents

Po-Yuam Lin holds a patent for a system and method for detecting alpha-methylacyl-CoA racemase (AMACR) and prostate cancer. This detection system is designed to determine alpha-methylacyl-CoA (AMACR) levels in bodily samples. The system includes at least one reaction solution that generates hydrogen peroxide (HO) upon combination with AMACR in the sample. The reaction solution features a (2R)-2-methylacyl-CoA epimer, which can be chirally inverted by AMACR to a (2S)-2-methylacyl-CoA epimer. An enzyme is also included to carry out beta oxidation with the (2S)-2-methylacyl-CoA epimer, resulting in the generation of hydrogen peroxide.

Career Highlights

Po-Yuam Lin is affiliated with Case Western Reserve University, where he continues to advance research in medical diagnostics. His work is characterized by a commitment to innovation and improving healthcare outcomes through technology.

Collaborations

He has collaborated with notable colleagues, including Chung-Chiun Liu and Laurie Dudik, to further enhance the impact of his research and inventions.

Conclusion

Po-Yuam Lin's contributions to the field of prostate cancer detection exemplify the importance of innovation in medical technology. His patented system represents a significant advancement in diagnostic capabilities, potentially leading to better patient care and outcomes.